Welspun Living reports Q4 results in line with expectations with Ebitda falling 11.9% YoY but up 12.6% QoQ to 3.2 billion.
Management of Welspun Living remains cautiously optimistic despite ongoing tariff uncertainties and geopolitical challenges.
The company strategically diversified and reduced exports to the US, expanding to the UK, EU, and other emerging markets.
Systematix maintains a 'Buy' rating, forecasting near-term headwinds while being confident in the company's resilient core business and growth in emerging segments.